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screening for type 2 diabetes
Screen women with gestational 
diabetes for type 2 diabetes
One way to reduce type 2 diabetes would be 
to target women with gestational diabetes.1 
Maternity services are increasingly screening 
women and treating gestational diabetes, 
after the demonstration of significant perinatal 
benefits.2
Within 10 years, 35-60% of women with 
gestational diabetes will develop type 2 
diabetes.3 These women are an already 
identified high risk group. Their children are 
also more likely to be obese and share a genetic 
propensity to type 2 diabetes.4
Following up women with gestational 
diabetes allows the targeting of two high risk 
people without additional screening. Many 
health service contacts are made in the first 
year of a child’s life, therefore interventions 
may be easily delivered. Also, many women are 
receptive to health advice around the time of 
a birth when new lifestyle patterns are being 
established.
Improved follow-up of these women with 
promotion of diet, exercise, and pharmacology, 
together with prolongation of breast feeding 
and subsequent healthy infant feeding is likely 
to be effective for mother, child, and the health 
service.
Mark Sillender consultant obstetrician and gynaecologist 
Kaleeya Hospital, Fremantle, Wa 6158, australia 
marksillender@hotmail.com
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Self monitoring of blood 
glucose: the cost to patients
Simon et al found that glucose self monitoring 
by patients with non-insulin treated type 
2 diabetes increased NHS costs without 
benefiting glycaemic control.1 Less intensive 
and more intensive self monitoring cost £92 
(€117; $182) and £84 more than usual care.
Financial cost is just one factor to consider 
when weighing the benefits and costs of 
interventions. Patients who self monitored were 
more anxious and depressed than controls. 
Another cost is the time it takes to self monitor 
three times daily for two days a week2 when 
each self monitoring episode takes around 
three minutes.3
Self monitoring at the prescribed frequency 
would take 15.6 hours annually. For working 
age adults, the wage rate represents the gain 
from working an hour and the opportunity cost 
of an hour spent on unpaid activities, and it can 
be used to translate time costs into monetary 
terms.4 Using the 2005-6 adult minimum wage 
(about £5), 15.6 hours is worth £78—nearly 
as much as the additional NHS costs of the 
intervention. Valued at the average wage rate, 
time costs would greatly exceed the NHS costs.
People who develop self care 
recommendations should recognise the time 
requirements placed on patients. Although 
the NHS does not pay these costs, they 
affect patients’ willingness to comply with 
recommendations. Time costs may help explain 
why at the end of the first year only 67% of 
patients in the less intensive group and 52% in 
the more intensive group still self monitored.2 
For patients who stopped monitoring, the staff 
effort paid for by the NHS, and some of the 
supplies, were wasted.
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Why patients who self  
monitor glucose might be  
more depressed
O’Kane et al suggest that the negative effect of 
self monitoring of blood glucose might relate to 
“the enforced discipline of regular monitoring 
without any tangible gain.”1 I suggest an 
alternative explanation based on personal 
experience. In the first few years after diagnosis, 
many people do not really believe that they 
“have” diabetes because they feel well, 
especially those with easily controlled disease 
who are unlikely to have polyuria and polydipsia. 
The diagnosis only emerges from blood tests. 
They just take the pills and slip back into 
believing that “I don’t really have it, I could get 
over it, it will go away if I exercise and eat better.” 
Self monitoring of blood glucose throws it in 
your face. You can’t deny that two pieces of pie 
did unmentionable things to your postprandial 
value. You must admit again and again that you 
have diabetes. Unmonitored patients do not 
have this constant reality check.
During 12 months of observation, monitored 
patients were more depressed because they 
confronted the reality of a chronic disease, 
while unmonitored patients could believe 
what they wanted as long as they followed the 
regimen. The real difference will come with the 
deterioration in their pancreatic function, when 
unmonitored patients will have to face the 
music too. At that point they may look “more 
depressed” while monitored patients might be 
more at ease with their diagnosis. One year is 
too short a time to incorporate the reality of a 
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chronic disease into one’s mindset. Only a much 
longer project would validate the differences in 
depression and long term outcome.
lucy M Candib family doctor and trainer, Family Health 
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broadening access to medicine
editorial opposes social justice 
and equal opportunity
Ip and McManus seem to conflate “political 
correctness” with the principles of social justice 
and equal opportunity that underpin widening 
access initiatives.1 Shouldn’t we have social 
justice and equal educational opportunity within 
the medical profession? Or do the authors 
think that these goals have already been 
“meritocratically” achieved and are redundant? 
As Wright states, their observation on the 
association between social class and intellect, 
with its causal overtones, requires challenge and 
more nuanced consideration.2
The authors selectively quote evidence from 
a report on the influence of schooling on higher 
education achievement.3 The report found that 
students from independent schools (which 
around 30% of medical applicants in the UK 
have attended) achieve less than students from 
the state sector with equivalent A level grades. 
Ip and McManus also misrepresent the effect 
of school performance, which was reported as 
varied. The report also says that subjects allied 
to medicine and engineering have the strongest 
school performance effects.3 
They also contend that such initiatives are 
costly but make no reference to comparative 
data for the cost of conventional routes and 
students. Such initiatives will have associated 
costs, but we need comparative cost data to 
make valid and robust conclusions about their 
relative worth.
The authors conclude by asking whether 
it is “worth our while to widen participation, 
particularly if this risks reducing standards?” But 
do we really risk reducing standards? Retention 
rates are similar for the extended medical 
degree programme, and some students have 
results in the top 20% of their cohort. Research 
shows that adjusted entry criteria students from 
poor performing schools have equivalent results 
in first year final exams.4
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The extended medical degree 
programme at King’s
We would like to comment on Ip and McManus’s 
editorial on our extended medical degree 
programme (EMDP) at King’s College London.1
Firstly, our aim in setting up the programme 
was to enable bright motivated pupils from inner 
London state schools to become doctors; we 
had no intention of future matching of doctors to 
patients, in terms of class or ethnic origin.
Secondly, the 50 EMDP places are extra 
places, funded by the Higher Education Funding 
Council for England and added to the 360 places 
on our conventional medical course.
Thirdly, we believe that we are not lowering 
standards with the EMDP students. Although 
they are given lower A level offers to enter 
medical school, once they are on the course they 
have to take the same assessments and achieve 
the same pass mark as conventional students.
Interestingly, in the two most recent 
assessments, more than 20% of the EMDP 
students came in the top 20% of the whole 
cohort. The increased diversity provided 
by the EMDP students has had a positive 
impact, and the medical school and these 
students are justifiably proud of their 
achievements.
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lessons in medical school 
access from America
Ip and McManus worry that widening 
participation schemes for entry to medical 
school sacrifice “equality of opportunity” 
because applicants are not all “treated 
uniformly.”1 But it could be argued that those 
entering medical school through such schemes 
have not had equal opportunity to attend high 
achieving schools.1
A scheme run by a university in the US might 
solve several of the objections to such schemes 
and help redress the class divisions in the 
UK school system. Rather than considering 
exam results only, the university gives weight 
to the student’s rank within the school. An 
admissions policy that requires students 
to be in the top X% of their year treats all 
students uniformly and recognises that it can 
be as difficult to get a B grade from a poorly 
performing school as an A grade from a high 
performing school. If such a scheme were 
adopted, would it affect the distribution of 
the children of ambitious professionals in UK 
schools—would middle class parents choose 
schools in deprived areas to “game” the 
system?
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Is the extended medical degree 
programme misguided?
If tomorrow’s doctors should reflect the social 
and ethnic diversity of our country,1 why is the 
high proportion (91%) of ethnic minorities 
among extended medical degree programme 
students applauded when half the conventional 
students are from this group anyway?
Perhaps we need a selection policy to ensure 
that the ethnic mix of our doctors reflects the 
composition of our society (8-9%).2
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